ľ¹Ï¸£ÀûÓ°ÊÓ

Dr. S. (Shahab) Abtahi

David de Wiedgebouw
Universiteitsweg 99
Kamer 1.01
3584 CG Utrecht

Dr. S. (Shahab) Abtahi

Assistant Professor
Pharmacoepi. and Clinical Pharmacol.
+31 6 18 821 373
s.abtahi@uu.nl

Shahab is currently appointed as Assistant Professor at Division of Pharmacoepidemiology and Clinical Pharmacology of UIPS at Utrecht ľ¹Ï¸£ÀûÓ°ÊÓ. He did his postdoc at Utrecht ľ¹Ï¸£ÀûÓ°ÊÓ between 2021-2023, defended his PhD in ‘Pharmacoepidemiology’ at Maastricht ľ¹Ï¸£ÀûÓ°ÊÓ in 2021, finished a master course in 'Vitality and Ageing' at Leiden ľ¹Ï¸£ÀûÓ°ÊÓ in 2016, and graduated in 'General Medicine' from Tehran ľ¹Ï¸£ÀûÓ°ÊÓ of Medical Sciences in 2011.

Shahab has a strong interest in studying drugs utilisation and outcomes using real-world data from electronic healthcare databases, with a particular focus on multi-database studies and signal detection methodologies. Some of the major projects they finished in the past few years are:

 

Shahab is currently working, amongst others, on the projects below: 

  • Treat-PRYSM: The pursuit of non-invasive treatment for intracranial aneurysms to PRevent aneurYSMal subarachnoid haemorrhage 
  • U'RE-SPARED: the Usability of REal-world data and Signal detection methodologies to explore Preventive pharmacotherapies Against RhEumatoiD arthritis
  • ISPE Updated guidance on database selection for pharmacoepidemiologic studies
  • ADEPT: Antiseizure meDication Exposure and Pregnancy and neonaTal outcomes research
  • ISPE DQ paper: Guidance and best practices for data quality checking and benchmarking of results in large multi-database pharmacoepidemiologic studies using heterogeneous data sources
  • Sapere Aude: Hypothesis-free screening for adverse events: A new approach in drug safety research
  • ACESO: A multinational big data Covid-19 epidemiological study on post-infection outcomes

 

Besides research, he teaches several courses in pharmacoepidemiology, and supervises PhD, master and bachelor students at Utrecht ľ¹Ï¸£ÀûÓ°ÊÓ. He is also course coordinator, instructor, and course developer at the Eu2P, the first European training programme in pharmacovigilance and pharmacoepidemiology.

Furthermore, he acts as chair of .